Secondary Logo

Journal Logo

July 1st, 2004 - Volume 36 - Issue 3
pp: 765-882


Maternal Toxicity With Continuous Nevirapine in Pregnancy: Results From PACTG 1022

Hitti, Jane; Frenkel, Lisa M.; Stek, Alice M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):772-776, July 1st, 2004.


Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3

Plana, Montserrat; Garcia, Felipe; Oxenius, Annette; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):791-799, July 1st, 2004.


The Impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316

Cunningham, Coleen K.; Balasubramanian, Rajalakshmi; Delke, Isaac; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):800-807, July 1st, 2004.

Effect of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients With Chronic HIV Infection: A Randomized Pilot Study

García, Felipe; Plana, Montserrat; Arnedo, Mireia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):823-830, July 1st, 2004.


Clinical Science


Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa: A 2002 Consensus Conference in Zambia

Zulu, Isaac; Schuman, Paula; Musonda, Rosemary; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):831-834, July 1st, 2004.


Infection With HIV Type 1 Group M Non-B Subtypes in Individuals Living in New York City

Achkar, Jacqueline M.; Burda, Sherri T.; Konings, Frank A. J.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):835-844, July 1st, 2004.

Early Markers of HIV-1 Disease Progression in a Prospective Cohort of Seroconverters in Bangkok, Thailand: Implications for Vaccine Trials

Buchacz, Kate; Hu, Dale J.; Vanichseni, Suphak; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):853-860, July 1st, 2004.


Virologic Outcome After Switching From a Nucleoside Reverse Transcriptase Inhibitor to Tenofovir in Patients With Undetectable HIV-1 RNA Plasma Level

Wirden, Marc; Marcelin, Anne Geneviève; Tubiana, Roland; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):876-878, July 1st, 2004.

Identification of a High-Risk Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil, Using a Sensitive/Less-Sensitive Assay: An Update

Barroso, Paulo Feijó; Harrison, Lee H.; de Fátima Melo, Maria; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(3):880-881, July 1st, 2004.